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Whereas the capacity of IgG antibodies to induce a cytolytic activity in certain 
lymphocytes (K cells) is well established (1), that of IgM antibodies is considered 
to  be  of  doubtful  significance  (2,  3).  In  fact,  it  has  been  shown  that  IgM 
antibodies may inhibit the IgG-dependent reaction  (4).  However,  Lamon et al. 
(5, 6) have now provided evidence that IgM antibodies may induce cytolysis of 
murine  sarcoma  virus-induced  mouse tumor cells  by  mouse lymphocytes,  in- 
cluding T cells. It has also recently been reported that a significant proportion of 
human peripheral T lymphocytes form rosettes with IgM-coated erythrocytes by 
means  of receptors  distinct  from the  cellular  Fc  receptors  for  IgG  (7,  8).  We 
therefore reinvestigated the question of the relative capacities of IgG and IgM to 
induce lymphocyte-mediated target cell lysis in man. We made use of a plaque 
assay  in  which  K-cell  activity  is  determined  on  the  level  of the  individual 
effector cells  (9,  10). 
Materials and Methods 
Highly purified lymphocytes from defibrinated human blood were used (11). The lymphocytes 
were used either untreated or treated with neuraminidase (NANAase, from Clostridium perfrin- 
gens)  (12).  Target cells in the cytolytic reactions were bovine erythrocytes (Eb).  Cell-mediated 
erythrolysis was induced with either the IgG or the IgM fraction of a rabbit anti-Eb serum (13). 
The protein fractions were obtained by gel exclusion on Sephadex G-200 (Pharmacia Fine Chemi- 
cals,  Uppsala,  Sweden).  The  concentration of specific anti-Eb  antibodies was determined by 
measuring binding of ~25I-labeled protein to Eb.  Different dilutions of trace-labeled IgG or IgM 
were added to a constant number of Eb in excess. '~I-labeled IgG or IgM fraction from a  normal 
rabbit serum, previously absorbed with Eb,  were used to determine the background that was 
subtracted. The antibody concentration was 9.5% of the protein in the IgG fraction and 7% in the 
IgM fraction. 
Cell-mediated erythrolysis  on the single cell level was determined as described (13). In brief, 0.5 
ml of 1% Eb (--10  s cells) was added to poly-L-lysine-treated coverslips in plastic Petri dishes (35  × 
10 mm). They were incubated for 45 min and washed to form dense Eb monolayers. To these were 
added 0.5-ml dilutions of the inducing rabbit antibodies and 0.5 ml lymphocytes (0.5-4  ×  10e/ml, 
corresponding to lymphocyte/Eb ratios of 1:20-1:80  per mm  2 on the coverslips). The medium was 
supplemented tissue culture medium RPMI 1640 (Biocult, Paisley, Scotland) and contained 10% 
heat-inactivated fetal bovine serum (FBS) (Flow Co., Irvine, Scotland). After gentle agitation the 
dishes were incubated at 37°C in air plus 5% CO2. Lymphocyte-free  controls and controls contain- 
ing lymphocytes and  normal rabbit  serum fractions or FBS but no  antiserum were set up  in 
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parallel.  In the inhibition experiments, purified human IgG or tgM proteins were added to the 
plates before addition of the lymphocytes. IgG was isolated from normal serum by DEAE-cellulose 
chromatography (14). The IgM was a cryogloblin from a patient with Waldenstr6m's macroglobuli- 
nemia.  It was purified by four  precipitations in an ice bath,  followed by passage at 37°C  over 
Sepharose-coupled protein A from Staphylococcus aureus (Pharmacia Fine Chemicals Inc.). 
For enumeration of the number of plaque-forming cells (PFC), the monolayers are briefly fixed 
with dilute glutardialdehyde  (GA)  (13).  Eb  lysis is reflected by the formation of clear zones of 
irregular shapes and different sizes. An area corresponding to ->5 lysed Eb is defined as a plaque. 
In general, 1 or rarely 2 or more lymphocytes are seen associated with -80% of the plaques. The 
number of PFC as percentage of the total number of lymphocytes added is calculated as 100 × a  × 
b/c  x  d,  where  a  denotes total  area of dish,  b  denotes number of plaques counted  in a  phase 
contrast microscope, c denotes number of lymphocytes added, and d denotes total area screened for 
counting plaques in randomly chosen fields. This estimate is based on the assumption that one K 
cell does not form more than one plaque. However, since some of the larger plaques may be formed 
by confluency and since some of the minor plaques may escape detection, these estimates give 
minimal numbers and the actual number of PFC may be larger (10,  13). 
Surface  markers  were determined in situ on lymphocytes either associated  with plaques or 
found on the intact Eb monolayers (13).  Lymphocytes with complement receptors were assayed by 
binding of EAC (E, sheep erythrocytes; A, IgM fraction of rabbit anti-sheep erythrocyte serum; C, 
C6-deficient rabbit serum) to the lymphocytes on unfixed coverslips and fixation with 1% GA after 
incubation for 60 min at 37°C.  Surface bound immunoglobulin (SIg) was determined m  situ by 
direct immunofluorescence with FITC-labeled rabbit anti-human F(ab')~ reagent, added after 20-s 
fixation of the plates with 0.5-1% GA.  Receptors for Helix pomatm  A  hemagglutinin (HP) were 
assayed on lymphocytes that had been treated with NANAase in Trls-buffered Hanks' solution 
containing 0.2% human serum albumin before addition to the monolayers  (12).  Staining of the 
plates with TRITC-labeled HP protein was performed as described for SIg staining. Double marker 
staining (HP-SIg) with TRITC-labeled HP protein followed by FITC-labeled anti-immunoglobulin 
was performed according to Hellstr6m et al.  (15). 
Results and  Discussion 
The time-course of the IgM-dependent plaque formation by either untreated 
or NANAase-treated lymphocytes is shown in Fig.  1. As in the IgG-dependent 
reaction NANAase-treated lymphocytes are significantly more active than un- 
treated  lymphocytes.  However,  while  the  IgG-dependent  reaction  under  the 
present conditions proceeds linearly to completion at about 20 h  of incubation 
(16), the IgM-dependent reaction is slower but proceeds for approximately 40 h 
before it stops. These results are compatible with those of the rosette tests which 
indicate  that  IgM  receptors  on  lymphocytes require  prolonged  incubation  at 
37°C to become fully expressed (7, 8). While the minimal number of PFC for IgG 
at optimal concentration in nine different donors was 5.6 _  1.2% of the lympho- 
cytes added (mean _+ SE), it was 2.0 _  0.8% for IgM, in spite of the fact that the 
molar concentration of IgM antibodies used in these experiments was 2 × higher 
than that of the IgG antibodies.  The mean size of the IgM plaques was smaller 
(-5-10  lysed Eb/plaque)  than  that  of the  IgG-plaques  (-25  lysed Eb/plaque). 
Taken together, these results would seem to suggest that the effector cells are a 
small subset of the lymphocytes which form rosettes with IgM-coated Eb (7, 8, 
17), and that the IgM-dependent cytolytic system is less efficient than the IgG 
dependent one. However, these questions need to be explored further. Thus, the 
optimal reactions in the plaque test are obtained at low lymphocyte/Eb ratios 
(13,  16),  and  the  lowest number  of lymphocytes giving the  maximal  relative 
frequency of PFC has not as yet been determined. The optimal concentration of 
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FIG.  1.  Time-course of plaque formation. Eb monolayers treated with 10.5 ~g rabbit IgM 
antibodies and 2  x  108 lymphocytes/dish (total vol 1.0 ml). Lymphocytes either untreated 
(circles)  or  treated  with  NANAase  before  addition to  the  dishes  (dots).  Ordinate:  total 
number of plaques counted,  corrected  by subtracting plaques found in control  (-<4). Ab- 
scissa:  hour of incubation. 
Fig.  2  shows  the  results  of a  typical  inhibition  experiment,  with  human 
immunoglobulins  used  as  inhibitors.  The  lymphocytes  were  from  the  same 
donor.  The results indicate that the immunoglobulin receptors on the effector 
cells in these two cytolytic systems are different.  This is similar  to what has 
been noted for rosette formation  (7, 8,  17). 
Very similar  results have been obtained  in experiments  in which the IgM- 
induced  cellular  cytotoxicity was established  by measuring  5'Cr release from 
labeled Eb in suspension  (unpublished).  Several reasons may account for pre- 
vious negative results with IgM antibodies (2-4). One possible explanation of the 
present positive results may be the relative inagglutinability  of Eb  (18) which 
facilitates their coating with the critical amounts of IgM required for cytotoxic- 
ity.  The  present  results  do  not  contradict  previous  findings  of an  inhibitory 
activity of IgM antibodies  on the IgG-dependent  reaction  (4).  This  inhibition 
reflects  a  competition  for  antigenic  sites  on  the  target  cells  and  obviously 
depends on the quantitative balance of the different reactants.  Inhibition should 
become particularly important if the IgG- and IgM-dependent effector cells were 
different  lymphocytes.  That  this  may  be  the  case  to  a  significant  extent  is 
suggested by surface  marker  analysis.  Typical results  of an  experiment  per- 
formed with NANAase-treated lymphocytes are given in Table I. The distribu- 
tion on the original lymphocytes of the three surface markers was the same as 
that earlier described (12).  The surface marker profile of the lymphocytes seen 
on the intact monolayers was similar to that of the original  preparation,  thus 
suggesting a random distribution of the lymphocytes in these areas. In contrast, 
the plaque-associated cells had different profiles, in accord with the notion that 1378  W~kHLIN  ET  AL.  BRIEF  DEFINITIVE  REPORT 
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Fro. 2.  Inhibition  of IgG-dependent (solid lines) or IgM-dependent (broken lines) plaque 
formation by human IgG (dots) or IgM (circles). Ordinate:  total number  of plaques counted. 
Abscissa: milligrams inhibitor per dish (total vol 1.2 ml). For other details see Fig. 1 and 
text. 
TABLE  I 
Surface Marker Profiles 
Lymphocytes* 
Percent cells with surface  marker 
EAC  +  SIg  +  HP  + 
Double stalmug 
Slg*-Hp  +  SIg+-Hp  -  SIg--HP  + 
Original  suspenmon  23  10  75 
IgG-dependent  reaction§ 
Plaque associated  (PFC)  47  11  27 
On monolayer  21  13  66 
IgM-dependent  reactions 
Plaque  associated  (PFC)  7  11  58 
On monolayer  ND  12  69 
12  0  21 
7  5  62 
12  0  43 
5  3  66 
ND, not done 
* Lymphocytes treated wlth NANAase  before  incubation on Eb monolayers (12,  13) 
§ Eb monolayers treated wlth 1.5  ~g  rabbit  IgG antlbody and 2 × 106  lymphocytes/dmh,  total  vol 1  0 ml Time of  mcubatlon. 20  h, 
minimal number of  PFC 5.9  % of  lymphocytes added 
* Es  monolayerstreatedwlth 10.5  ~grabblt  IgM antlbodyand2 × 10"lymphocytes/dlsh  Time of  incubation:  40h, mmlmalnumber 
of  PFC 1.8% 
the majority of the plaque-associated cells represent PFC,  i.e.,  K  cells (10,  13). 
As previously shown,  -50%  of these cells  in the IgG system had complement 
receptors  (EAC +)  and  -30%  were  HP  +,  while the percentage  SIg  ÷ cells  was 
similar to that seen in the original preparation and on the intact monolayer. 
Double staining of these cells for SIg and HP receptors  (15)  indicated that all 
plaque-associated  SIg  +  cells  also  were  HP  ÷.  Thus,  these  cells  belong to  the 
subset of the HP  ÷ lymphocytes  (10-20%  in normal blood) which also have  Fc 
receptors for IgG and externally adsorbed surface IgG (12). It will be noted that 
the SIg-HP profile of the lymphocytes studied by double labeling on the intact 
monolayer was different. 
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cells  in  the  IgM-dependent  reaction  was different  in that  only few cells had 
complement receptors while ~60% were HP  ÷. Moreover, -80% of the latter were 
SIg-.  Therefore a  large fraction  of the IgM-dependent  K  cells are probably T 
cells which have previously been shown to be HP+-SIg--EAC -  (12).  These cells 
are distinct from the majority of the IgG-dependent effector cells.  However, it 
can not be excluded that they also have Fc receptors for IgG and IgG-dependent 
cytolytic potential. The degree of overlap between different effector cell types as 
well as the cellular origin  of the immunoglobulin  receptors involved requires 
further studies. 
In conclusion,  we have  shown that  IgM may induce  a  cytolytic activity in 
human  T  cells as it  does in the mouse  (5,  6).  The biological role of this new 
effector mechanism remains to be established.  Since these antibody-dependent 
killer cells are a  subset of the peripheral  T-cell population,  it will be of great 
interest to elucidate their relationship  to other T-cell subsets, in particular  to 
the antibody-independent T-killer cells (CTL) (1). 
Summary 
When monolayers of bovine erythrocytes (Eb) were exposed to purified human 
blood lymphocytes and either IgG or IgM fractions of rabbit anti-Eb serum, clear 
zones  (plaques)  appeared  where  Eb  had  been  lysed  by  antibody-dependent 
effector cells (K cells). IgG-dependent plaque formation was complete by 20 h of 
incubation,  while  the  IgM-dependent  reaction  required  40  h.  The  estimated 
minimal numbers of plaque forming cells (PFC) were 5.6% (IgG) and 2.0% (IgM) 
of the  added  lymphocytes.  Inhibition  experiments  with  human  IgG  or  IgM 
indicated  that  different  immunoglobulin  receptors on  the  effector cells were 
involved in the two systems. In the IgG system, -50% of the PFC had comple- 
ment receptors and -30% receptors for Helix pomatia A hemagglutinin  (HP). In 
the IgM system, <10% of the PFC had complement receptors, while -60% had 
HP receptors.  The  results  suggest that  a  subset of human  T  cells have  IgM- 
dependent  K-cell potential.  These  ceils are different from the majority of the 
IgG-dependent K  cells. 
Received for publication  19 Augus~ 1976. 
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